The Imperfect Template: Navigating Next-Generation Sequencing with FFPE Samples

The advent of Next-Generation Sequencing (NGS) has transformed our understanding of the genome, demanding high-quality input material to generate massive datasets with low error rates. This raises a critical logistical question for translational research: Are FFPE samples suitable for NGS? Given that FFPE samples suffer from fragmentation and chemical modification, one might assume they are incompatible with the stringent requirements of modern sequencing. However, the reality is nuanced: FFPE samples are not only suitable for NGS, they have become a mainstay of clinical genomics, provided specific adaptations are made.

The Problem of Artifacts

The primary concern with using FFPE for NGS is the introduction of artifacts. As previously noted, formalin fixation leads to fragmentation and base modification. Specifically, the deamination of cytosine to uracil is a common artifact. If uncorrected, standard PCR amplification during library prep will read this uracil as thymine, resulting in a false C>T (G>A) mutation in the sequencing data. In a clinical setting, where a single mutation can dictate treatment, these false positives are unacceptable.

Technological Adaptations

The industry has responded to these challenges with specialized workflows. Standard NGS protocols often fail with FFPE material, but “FFPE-optimized” kits have become standard.

• DNA Repair Enzymes: Many library preparation protocols now include a pre-treatment step using repair enzymes (such as Uracil-DNA Glycosylase or UDG). These enzymes recognize and remove the artificial uracil bases, effectively reversing the formalin-induced damage before sequencing amplification begins. This drastically reduces the false-positive rate.
• Fragmentation Tolerance: NGS technologies, particularly Illumina’s sequencing-by-synthesis, naturally require short fragments of DNA. Since FFPE DNA is already fragmented to sizes often ideal for NGS (around 200-300bp), the lack of mechanical shearing required for fresh DNA can actually be an advantage, simplifying the workflow.
• Unique Molecular Identifiers (UMIs): To further combat errors, advanced NGS workflows utilize UMIs. These are unique molecular tags attached to each original DNA molecule before amplification. By grouping reads with the same tag, bioinformaticians can distinguish true biological mutations from PCR duplicates or FFPE artifacts, effectively filtering out the noise created by the preservation process.tissue block

Clinical Viability

Today, FFPE is widely used for targeted panel sequencing, such as the Illumina TruSight Oncology series or the Ion Torrent Oncomine panels. These panels focus on specific hotspots rather than the whole genome, allowing for deeper coverage and higher tolerance for lower-quality input material.

While whole-genome sequencing (WGS) of FFPE is possible, it is generally avoided for high-resolution structural variant calling due to the fragmentation. However, for identifying point mutations, insertions/deletions, and copy number variations in cancer genes, FFPE samples perform remarkably well.

Conclusion

Are FFPE samples suitable for NGS? The answer is yes, but with the caveat that they require “best practice” handling. They represent an imperfect template that demands rigorous quality control, specialized repair enzymes, and sophisticated bioinformatics filtering. Despite these hurdles, the ability to sequence FFPE samples bridges the gap between clinical archives and precision medicine, allowing us to unlock the genetic code of millions of stored samples that would otherwise remain silent.